| A practical approach to nutrition, protein-energy wasting, sarcopenia, and cachexia in patients with chronic kidney disease RM Hanna, L Ghobry, O Wassef, CM Rhee, K Kalantar-Zadeh Blood purification 49 (1-2), 202-211, 2020 | 307 | 2020 |
| Plant-dominant low-protein diet for conservative management of chronic kidney disease K Kalantar-Zadeh, S Joshi, R Schlueter, J Cooke, A Brown-Tortorici, ... Nutrients 12 (7), 1931, 2020 | 201 | 2020 |
| Burden of anemia in chronic kidney disease: beyond erythropoietin RM Hanna, E Streja, K Kalantar-Zadeh Advances in therapy 38 (1), 52-75, 2021 | 189 | 2021 |
| A case of novel coronavirus disease 19 in a chronic hemodialysis patient presenting with gastroenteritis and developing severe pulmonary disease AJ Ferrey, G Choi, RM Hanna, Y Chang, E Tantisattamo, K Ivaturi, E Park, ... American journal of nephrology 51 (5), 337-342, 2020 | 162 | 2020 |
| Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence RM Hanna, M Barsoum, F Arman, U Selamet, H Hasnain, I Kurtz Kidney international 96 (3), 572-580, 2019 | 98 | 2019 |
| Distinguishing 3 classes of corpus callosal abnormalities in consanguineous families RM Hanna, SE Marsh, D Swistun, L Al-Gazali, MS Zaki, GM Abdel-Salam, ... Neurology 76 (4), 373-382, 2011 | 71 | 2011 |
| Approach and management of hypertension after kidney transplantation E Tantisattamo, MZ Molnar, BT Ho, UG Reddy, DC Dafoe, H Ichii, ... Frontiers in Medicine 7, 229, 2020 | 69 | 2020 |
| Advances in autosomal dominant polycystic kidney disease: a clinical review N Nobakht, RM Hanna, M Al-Baghdadi, KM Ameen, F Arman, E Nobahkt, ... Kidney medicine 2 (2), 196-208, 2020 | 61 | 2020 |
| Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension RM Hanna, EA Lopez, H Hasnain, U Selamet, J Wilson, PN Youssef, ... Clinical kidney journal 12 (1), 92-100, 2019 | 61 | 2019 |
| Minimal change disease onset observed after bevacizumab administration RM Hanna, E Lopez, J Wilson, S Barathan, AH Cohen Clinical Kidney Journal 9 (2), 239-244, 2016 | 45 | 2016 |
| The utility and accuracy of four equations in predicting sodium levels in dysnatremic patients RM Hanna, WT Yang, EA Lopez, JN Riad, J Wilson Clinical Kidney Journal 9 (4), 530-539, 2016 | 42 | 2016 |
| Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy M Shye, RM Hanna, SS Patel, N Tram-Tran, J Hou, C Mccannel, M Khalid, ... Clinical Kidney Journal 13 (6), 969-980, 2020 | 38 | 2020 |
| Thrombotic microangiopathy and acute kidney injury induced after intravitreal injection of vascular endothelial growth factor inhibitors VEGF blockade-related TMA after … RM Hanna, NT Tran, SS Patel, J Hou, KD Jhaveri, R Parikh, U Selamet, ... Frontiers in Medicine 7, 579603, 2020 | 37 | 2020 |
| Intravitreal bevacizumab-induced exacerbation of proteinuria in diabetic nephropathy, and amelioration by switching to ranibizumab RM Hanna, L Abdelnour, H Hasnain, U Selamet, I Kurtz SAGE Open Medical Case Reports 8, 2050313X20907033, 2020 | 32 | 2020 |
| Renal-cerebral pathophysiology: the interplay between chronic kidney disease and cerebrovascular disease RM Hanna, A Ferrey, CM Rhee, K Kalantar-Zadeh Journal of Stroke and Cerebrovascular Diseases 30 (9), 105461, 2021 | 30 | 2021 |
| Acute kidney injury after pembrolizumab-induced adrenalitis and adrenal insufficiency RM Hanna, U Selamet, P Bui, SF Sun, O Shenouda, N Nobakht, ... Case Reports in Nephrology and Dialysis 8 (2), 171-177, 2018 | 27 | 2018 |
| Calcium transport in the kidney and disease processes RM Hanna, RS Ahdoot, K Kalantar-Zadeh, L Ghobry, I Kurtz Frontiers in Endocrinology 12, 762130, 2022 | 25 | 2022 |
| Prognostic nutritional index as a predictor of mortality in 101,616 patients undergoing hemodialysis Y Miyasato, RM Hanna, J Morinaga, M Mukoyama, K Kalantar-Zadeh Nutrients 15 (2), 311, 2023 | 20 | 2023 |
| Equivalent efficacy and decreased rate of overcorrection in patients with syndrome of inappropriate secretion of antidiuretic hormone given very low-dose tolvaptan RM Hanna, JC Velez, A Rastogi, MK Nguyen, MK Kamgar, K Moe, ... Kidney medicine 2 (1), 20-28, 2020 | 20 | 2020 |
| Thrombotic microangiopathy syndromes—Common ground and distinct frontiers RM Hanna, K Henriksen, K Kalantar-Zadeh, A Ferrey, R Burwick, ... Advances in chronic kidney disease 29 (2), 149-160. e1, 2022 | 18 | 2022 |
Kamyar Kalantar-ZadehProfessor of Medicine, University of CaliforniaCorreu electrònic verificat a uci.edu